Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2015

Open Access 01-05-2015 | Original Article

Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease

Authors: Alexander Broomfield, Mary G. Sweeney, Cathy E. Woodward, Carl Fratter, Andrew M. Morris, James V. Leonard, Lara Abulhoul, Stephanie Grunewald, Peter T. Clayton, Michael G. Hanna, Joanna Poulton, Shamima Rahman

Published in: Journal of Inherited Metabolic Disease | Issue 3/2015

Login to get access

Abstract

Background

Single large-scale mitochondrial DNA (mtDNA) deletions (SLSMDs) are amongst the most frequently diagnosed mtDNA disorders in childhood, yet their natural history remains poorly understood. We report the natural history of a large multicentre cohort of such children.

Methods

We reviewed case notes from three different UK centres to determine the clinical course of 34 patients (16 female, 18 male) with childhood-onset mitochondrial disease caused by SLSMDs. Kaplan–Meier analysis was used to compare survival of patients presenting with haematological features (Pearson syndrome) and those with nonhaematological presentations.

Results

The most frequent initial presentation was with isolated ptosis (16/34, 47 %). Eleven (32 %) patients presented with transfusion-dependent anaemia soon after birth and were diagnosed with Pearson syndrome, whilst ten were classified as having Kearns–Sayre syndrome, three as having progressive external ophthalmoplegia (PEO) and seven as having PEO-plus. Three patients did not conform to any specific mitochondrial syndrome. The most frequently affected organ during the disease course was the kidney, with documented tubular or glomerular dysfunction in 17 of 20 (85 %) cases who had detailed investigations. SLSMDs were present in blood and/or urine cells in all cases tested, indicating that muscle biopsy is not necessary for diagnosis in the paediatric age range. Kaplan–Meier survival analysis revealed significantly worse mortality in patients with Pearson syndrome compared with the rest of the cohort.

Conclusions

Mitochondrial disease caused by SLSMDs is clinically heterogeneous, and not all cases conform to a classical mitochondrial syndrome. Multisystem disease is the norm, with anaemia, renal impairment and endocrine disturbance being the most frequent extraneurological features. SLSMDs should be considered in the differential diagnosis of all children presenting with ptosis.
Appendix
Available only for authorised users
Literature
go back to reference Akaike M, Kawai H, Yokoi K et al (1997) Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia. Clin Cardiol 20:239–243CrossRefPubMed Akaike M, Kawai H, Yokoi K et al (1997) Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia. Clin Cardiol 20:239–243CrossRefPubMed
go back to reference Aure K, Ogier de Baulny H, Laforet P et al (2007) Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain 130:1516–1524CrossRefPubMed Aure K, Ogier de Baulny H, Laforet P et al (2007) Chronic progressive ophthalmoplegia with large-scale mtDNA rearrangement: can we predict progression? Brain 130:1516–1524CrossRefPubMed
go back to reference Berenberg RA, Pellock JM, DiMauro S et al (1977) Lumping or splitting? “Ophthalmoplegia-plus” or Kearns-Sayre syndrome? Ann Neurol 1:37–54CrossRefPubMed Berenberg RA, Pellock JM, DiMauro S et al (1977) Lumping or splitting? “Ophthalmoplegia-plus” or Kearns-Sayre syndrome? Ann Neurol 1:37–54CrossRefPubMed
go back to reference Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 33:775–779PubMed Bernard AM, Vyskocil AA, Mahieu P, Lauwerys RR (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin Chem 33:775–779PubMed
go back to reference Biousse V, Newman NJ (2001) Neuro-ophthalmology of mitochondrial diseases. Semin Neurol 21:275–291CrossRefPubMed Biousse V, Newman NJ (2001) Neuro-ophthalmology of mitochondrial diseases. Semin Neurol 21:275–291CrossRefPubMed
go back to reference Di Mauro S, Hirano M (1993–2014) Mitochondrial DNA deletion syndromes. In: Pagon RA, Adam MP, ardinger HH et al (eds) Genereview©[Internet]. Seattle(WA):University of Washington, Seattle Di Mauro S, Hirano M (1993–2014) Mitochondrial DNA deletion syndromes. In: Pagon RA, Adam MP, ardinger HH et al (eds) Genereview©[Internet]. Seattle(WA):University of Washington, Seattle
go back to reference Drachman DA (1968) Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18:654–674CrossRefPubMed Drachman DA (1968) Ophthalmoplegia plus. The neurodegenerative disorders associated with progressive external ophthalmoplegia. Arch Neurol 18:654–674CrossRefPubMed
go back to reference Grady JP, Campbell G, Ratnaike T et al (2014) Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain 137:232–34CrossRef Grady JP, Campbell G, Ratnaike T et al (2014) Disease progression in patients with single, large-scale mitochondrial DNA deletions. Brain 137:232–34CrossRef
go back to reference Herget-Rosenthal S, Poppen D, Husing J et al (2004) Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 50:552–558CrossRefPubMed Herget-Rosenthal S, Poppen D, Husing J et al (2004) Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 50:552–558CrossRefPubMed
go back to reference Holt IJ, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719CrossRefPubMed Holt IJ, Harding AE, Morgan-Hughes JA (1988) Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 331:717–719CrossRefPubMed
go back to reference Holt IJ, Harding AE, Cooper JM et al (1989) Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 26:699–708CrossRefPubMed Holt IJ, Harding AE, Cooper JM et al (1989) Mitochondrial myopathies: clinical and biochemical features of 30 patients with major deletions of muscle mitochondrial DNA. Ann Neurol 26:699–708CrossRefPubMed
go back to reference Inoue K, Nakada K, Ogura A et al (2000) Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 26:176–181CrossRefPubMed Inoue K, Nakada K, Ogura A et al (2000) Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 26:176–181CrossRefPubMed
go back to reference Jackson MJ, Schaefer JA, Johnson MA, Morris AA, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 118(Pt 2):339–357CrossRefPubMed Jackson MJ, Schaefer JA, Johnson MA, Morris AA, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. A study of 51 patients. Brain 118(Pt 2):339–357CrossRefPubMed
go back to reference Kearns TP, Sayre GP (1958) Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 60:280–289CrossRefPubMed Kearns TP, Sayre GP (1958) Retinitis pigmentosa, external ophthalmophegia, and complete heart block: unusual syndrome with histologic study in one of two cases. AMA Arch Ophthalmol 60:280–289CrossRefPubMed
go back to reference Krauch G, Wilichowski E, Schmidt KG, Mayatepek E (2002) Pearson marrow-pancreas syndrome with worsening cardiac function caused by pleiotropic rearrangement of mitochondrial DNA. Am J Med Genet 110:57–61CrossRefPubMed Krauch G, Wilichowski E, Schmidt KG, Mayatepek E (2002) Pearson marrow-pancreas syndrome with worsening cardiac function caused by pleiotropic rearrangement of mitochondrial DNA. Am J Med Genet 110:57–61CrossRefPubMed
go back to reference Krishnan KJ, Reeve AK, Samuels DC et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–279CrossRefPubMed Krishnan KJ, Reeve AK, Samuels DC et al (2008) What causes mitochondrial DNA deletions in human cells? Nat Genet 40:275–279CrossRefPubMed
go back to reference Lamont PJ, Surtees R, Woodward CE, Leonard JV, Wood NW, Harding AE (1998) Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child 79:22–27CrossRefPubMedCentralPubMed Lamont PJ, Surtees R, Woodward CE, Leonard JV, Wood NW, Harding AE (1998) Clinical and laboratory findings in referrals for mitochondrial DNA analysis. Arch Dis Child 79:22–27CrossRefPubMedCentralPubMed
go back to reference Lee HF, Lee HJ, Chi CS, Tsai CR, Chang TK, Wang CJ (2007) The neurological evolution of Pearson syndrome: case report and literature review. Eur J Paediatr Neurol 11:208–214CrossRefPubMed Lee HF, Lee HJ, Chi CS, Tsai CR, Chang TK, Wang CJ (2007) The neurological evolution of Pearson syndrome: case report and literature review. Eur J Paediatr Neurol 11:208–214CrossRefPubMed
go back to reference Lopez-Gallardo E, Lopez-Perez MJ, Montoya J, Ruiz-Pesini E (2009) CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion 9:314–317CrossRefPubMed Lopez-Gallardo E, Lopez-Perez MJ, Montoya J, Ruiz-Pesini E (2009) CPEO and KSS differ in the percentage and location of the mtDNA deletion. Mitochondrion 9:314–317CrossRefPubMed
go back to reference Manea EM, Leverger G, Bellmann F et al (2009) Pearson syndrome in the neonatal period: two case reports and review of the literature. J Pediatr Hematol Oncol 31:947–951CrossRefPubMed Manea EM, Leverger G, Bellmann F et al (2009) Pearson syndrome in the neonatal period: two case reports and review of the literature. J Pediatr Hematol Oncol 31:947–951CrossRefPubMed
go back to reference McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39–42PubMedCentralPubMed McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39–42PubMedCentralPubMed
go back to reference Morel AS, Joris N, Meuli R et al (2009) Early neurological impairment and severe anemia in a newborn with Pearson syndrome. Eur J Pediatr 168:311–315CrossRefPubMed Morel AS, Joris N, Meuli R et al (2009) Early neurological impairment and severe anemia in a newborn with Pearson syndrome. Eur J Pediatr 168:311–315CrossRefPubMed
go back to reference Pearson HA, Lobel JS, Kocoshis SA et al (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95:976–984CrossRefPubMed Pearson HA, Lobel JS, Kocoshis SA et al (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95:976–984CrossRefPubMed
go back to reference Pitceathly RD, Rahman S, Hanna MG (2012) Single deletions in mitochondrial DNA–molecular mechanisms and disease phenotypes in clinical practice. Neuromuscul Disord 22:577–586CrossRefPubMed Pitceathly RD, Rahman S, Hanna MG (2012) Single deletions in mitochondrial DNA–molecular mechanisms and disease phenotypes in clinical practice. Neuromuscul Disord 22:577–586CrossRefPubMed
go back to reference Poulton J, Deadman ME, Gardiner RM (1989) Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1:236–240CrossRefPubMed Poulton J, Deadman ME, Gardiner RM (1989) Duplications of mitochondrial DNA in mitochondrial myopathy. Lancet 1:236–240CrossRefPubMed
go back to reference Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G (1993) Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 2:23–30CrossRefPubMed Poulton J, Deadman ME, Bindoff L, Morten K, Land J, Brown G (1993) Families of mtDNA re-arrangements can be detected in patients with mtDNA deletions: duplications may be a transient intermediate form. Hum Mol Genet 2:23–30CrossRefPubMed
go back to reference Rahman S, Leonard JV (2000) Early onset of complete heart block in Pearson syndrome. J Inherit Metab Dis 23:753–754CrossRefPubMed Rahman S, Leonard JV (2000) Early onset of complete heart block in Pearson syndrome. J Inherit Metab Dis 23:753–754CrossRefPubMed
go back to reference Riera AR, Kaiser E, Levine P et al (2008) Kearns-Sayre syndrome: electro-vectorcardiographic evolution for left septal fascicular block of the his bundle. J Electrocardiol 41:675–678CrossRefPubMed Riera AR, Kaiser E, Levine P et al (2008) Kearns-Sayre syndrome: electro-vectorcardiographic evolution for left septal fascicular block of the his bundle. J Electrocardiol 41:675–678CrossRefPubMed
go back to reference Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327–1330CrossRefPubMed Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327–1330CrossRefPubMed
go back to reference Rowland LP (1983) Molecular genetics, pseudogenetics, and clinical neurology. The Robert Wartenberg lecture. Neurology 33:1179–1195CrossRefPubMed Rowland LP (1983) Molecular genetics, pseudogenetics, and clinical neurology. The Robert Wartenberg lecture. Neurology 33:1179–1195CrossRefPubMed
go back to reference Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders–past, present and future. Biochim Biophys Acta 1659:115–120CrossRefPubMed Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF (2004) The epidemiology of mitochondrial disorders–past, present and future. Biochim Biophys Acta 1659:115–120CrossRefPubMed
go back to reference Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC (1989) Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A 86:7952–7956CrossRefPubMedCentralPubMed Shoffner JM, Lott MT, Voljavec AS, Soueidan SA, Costigan DA, Wallace DC (1989) Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy. Proc Natl Acad Sci U S A 86:7952–7956CrossRefPubMedCentralPubMed
go back to reference Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912CrossRefPubMed Skladal D, Halliday J, Thorburn DR (2003) Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 126:1905–1912CrossRefPubMed
go back to reference van Straaten HL, van Tintelen JP, Trijbels JM et al (2005) Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics 36:193–199CrossRefPubMed van Straaten HL, van Tintelen JP, Trijbels JM et al (2005) Neonatal lactic acidosis, complex I/IV deficiency, and fetal cerebral disruption. Neuropediatrics 36:193–199CrossRefPubMed
go back to reference Yamashita S, Nishino I, Nonaka I, Goto Y (2008) Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions. J Hum Genet 53:598–606CrossRefPubMed Yamashita S, Nishino I, Nonaka I, Goto Y (2008) Genotype and phenotype analyses in 136 patients with single large-scale mitochondrial DNA deletions. J Hum Genet 53:598–606CrossRefPubMed
Metadata
Title
Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease
Authors
Alexander Broomfield
Mary G. Sweeney
Cathy E. Woodward
Carl Fratter
Andrew M. Morris
James V. Leonard
Lara Abulhoul
Stephanie Grunewald
Peter T. Clayton
Michael G. Hanna
Joanna Poulton
Shamima Rahman
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-014-9778-4

Other articles of this Issue 3/2015

Journal of Inherited Metabolic Disease 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.